Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers

NCT01166542 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Squamous Cell of the Head and Neck

Interventions

BIOLOGICAL: REOLYSIN
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Placebo

Sponsor

Oncolytics Biotech